FDA Chief Blames Big Pharma For 'Anemic' Biosimilars Sales
The U.S. Food and Drug Administration's leader on Wednesday placed blame on Big Pharma for the "anemic" biosimilars market and floated a four-part plan for strengthening sales of the copycat medicines....To view the full article, register now.
Already a subscriber? Click here to view full article